跳转至内容
Merck
CN

SML4129

YM155

≥97% (HPLC)

别名:

1-(2-Methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazolium bromide, 11-(2-Methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho(2,3-d)imidazolium bromide, 4,9-Dihydro-1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazinylmethyl)-1H-naphth[2,3-d]imidazolium bromide, Sepantronium bromide, Survivin Inhibitor I, Interleukin Enhancer-Binding Factor 3 Inhibitor, YM 155, YM-155

登录 查看组织和合同定价。

选择规格

变更视图

关于此项目

经验公式(希尔记法):
C20H19N4O3·Br
化学文摘社编号:
分子量:
443.29
MDL number:
NACRES:
NA.28
Assay:
≥97% (HPLC)
Form:
powder
Storage condition:
desiccated
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


Quality Segment

assay

≥97% (HPLC)

form

powder

storage condition

desiccated

color

white to beige

solubility

DMSO: 2 mg/mL, clear (warmed)

storage temp.

-10 to -25°C

Biochem/physiol Actions

Survivin expression inhibitor with anti-cancer efficacy in cultures and in vivo.
YM155 is a survivin expression inhibitor (effective conc. 10-100 nM for 6-48h; PC-3 & PCC-1 cells) that induces apoptosis in malignant melanoma and hormone-refractory prostate cancer (HRPC) cultures (GI50 = 2.3-11 nM) by targeting survivin gene promoter activity without affecting the expression of other IAPs or Bcl-2-related proteins even at concentrations as high as 100 nM. In a s.c. xenografted PC-3 tumor model in mice, 3-day continuous infusions of YM155 at 3 to 10 mg/kg induced massive tumor regression in vivo.

Disclaimer

Hygroscopic


存储类别

11 - Combustible Solids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库